StreetAlpha.app
Home › Stocks › VCEL

Vericel Corp (VCEL)

$57.88
▲ +0.70%
LAST CLOSE · NOV 17

Vericel makes cell therapies and biologic products for knee cartilage repair and severe burn care. It last closed at $57.88 on Nov 17, up 0.70% on the day. The average 12-month price target from 3 analysts is $69.33 (+19.8% from the last close), with a high of $75.00 and a low of $65.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).

AI Auto Pilots
Is VCEL in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$324.2M
+25.3% vs a year ago
Net income
$33.3M
+154.6% vs a year ago
EPS (diluted)
$0.64
+146.2% vs a year ago
Free cash flow
$57.9M
17.9% margin
Valuation
Market cap
$3.0B
51.0M shares
P/E
90.4
Price over 12 month EPS
Price to sales
9.1
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$133.5M
At Sep 30
Shareholder equity
$384.2M
Shares outstanding
51.0M
At Oct 29
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $156.2M$156.2MFY2021FY2022: $164.4M$164.4MFY2022FY2023: $197.5M$197.5MFY2023FY2024: $237.2M$237.2MFY2024FY2025: $276.3M$276.3MFY2025

From VCEL's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
3firms
3 Buy0 Hold0 Sell
Each firm's latest rating on VCEL in the past 90 days
Average 12-month target
$69.33
▲ 19.8% upside

Based on 3 analysts who set a price target on VCEL in the past 90 days. The average target is $69.33, with a high of $75.00 and a low of $65.00, compared with the last close of $57.88.

Low $65.00Avg $69.33High $75.00
Blue marker: last close $57.88
Highest target$75.00
Average target$69.33
Lowest target$65.00
Latest rating changes
Stephens & Co.Maintained
Nov 10Buy$68
Truist SecuritiesTarget raised
Nov 9Buy$52 → $65
HC Wainwright & Co.Target raised
Nov 6Buy$72 → $75
Truist SecuritiesTarget lowered
Oct 14Buy$58 → $52
TD CowenMaintained
Jul 31Buy$58
DateFirmActionRatingPrice target
Nov 10Stephens & Co.MaintainedBuy$68
Nov 9Truist SecuritiesTarget raisedBuy$52 → $65
Nov 6HC Wainwright & Co.Target raisedBuy$72 → $75
Oct 14Truist SecuritiesTarget loweredBuy$58 → $52
Jul 31TD CowenMaintainedBuy$58
Loading…

Technical Analysis

VCEL · as of the Nov 17 close · updated after every close
Uptrend, overbought

The stock is 16% above its 20 day and 25% above its 50 day average. It is 32% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 75), overbought. The nearest support is the Pivot S1 at $57.28, and the nearest resistance the Pivot at $57.98.

Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityHigh, 4.1%/day
Key levels
$59.7552 week high+3.2%
$59.75Swing high (Nov 11)+3.2%
$58.58Pivot R1+1.2%
$57.98Pivot+0.2%
$57.88Last close
$57.28Pivot S1−1.0%
$48.8520 day average−15.6%
$44.56Swing low (Jul 14)−23.0%
$44.03100 day average−23.9%
$43.5150 day average−24.8%
$39.62200 day average−31.5%
$28.9552 week low−50.0%
Indicators
RSI (14)74.69Overbought above 70Overbought
MACD4.65Above its signal lineBullish
Stochastic88.6Near the top of its rangeOverbought
ADX (14)39.5Trending up
Williams %R-9.2Oversold below −80, overbought above −20Overbought
CCI (20)83.8Oversold below −100, overbought above 100Neutral
Rate of change+40.9%Change over 10 sessionsBullish
ATR (14)$2.36Typical daily range, 4.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for VCEL

What happened before

See how VCEL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow VCEL usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How VCEL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in VCEL in the last 90 days.

Loading…

See today’s whale options flow across the market →

VCEL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●163 buying vs 146 selling
  • ●Held by funds +0.2 pts
  • ●Funds holding -2
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding320322−0.6%
In funds' top 10220.0%
Held by funds110.6%110.4%+0.2 pts
New / increased39 / 12463 / 123−12.4%
Reduced / sold out104 / 42100 / 22+19.7%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See VCEL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VCEL is in one of them and how their past VCEL trades turned out.

VCEL in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered VCEL in an article yet. Here's the latest on the wider market.

VCEL Congress Trades

All congress trades →
Trades, 12 months
2
Buys
0
0%
Sells
1
50%
People
1
Last filed Jul 1
Who traded VCEL · since 2026
Latest 2 filings
$15K – $50KTraded May 15, 2026Filed Jul 1, 2026
$15K – $50KTraded Mar 30, 2026Filed May 14, 2026
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchSell$15K – $50KMay 15, 2026Jul 1, 202647 d
Donald J TrumpExecutive branchOther$15K – $50KMar 30, 2026May 14, 202645 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Vericel

Vericel is a company in Burlington, Massachusetts that makes cell therapy and specialty biologic products for sports medicine and severe burn care. Its MACI product is an implant made from a patient's own cells that orthopedic surgeons use to repair knee cartilage. Epicel is a permanent skin replacement for severe burns, and NexoBrid is a product applied to burns to remove damaged tissue. Its customers include orthopedic surgeons and burn centers in the United States.

Headquarters
Burlington, MA